Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Irving Bryan
Relationship:   EVP, Chief Scientific ...
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   30,533    

Indirect Shares

  0      
Direct Value   $1,160,254    

Indirect Value

  $0      
Total Shares   30,533      
Total Value   $1,160,254      


Five Prime Therapeutics Inc
 $1,160,254 Five Prime Therapeutics Inc
 $1,160,254
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Five Prime Therapeutics Inc FPRX EVP, Chief Scientific ... 2019-05-15 30,533 2017-09-01 0    Premium*  
* Premium Members only  

Records found :    7         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
FPRX Five Prime Therapeutics I... EVP, Chief Scientific Officer   •       –      –    2019-05-15 4 D $9.17 $5,685 D/D (620) 30,533 0 -
FPRX Five Prime Therapeutics I... EVP, Chief Scientific Officer   •       –      –    2019-02-26 4 D $11.95 $13,360 D/D (1,118) 31,153 0 -
FPRX Five Prime Therapeutics I... EVP, Chief Scientific Officer   •       –      –    2019-02-25 4 A $0.00 $0 D/D 10,000 32,271 0 -
FPRX Five Prime Therapeutics I... EVP, Chief Scientific Officer   •       –      –    2018-09-01 4 D $14.00 $34,706 D/D (2,479) 22,271 0 -
FPRX Five Prime Therapeutics I... EVP, Chief Scientific Officer   •       –      –    2018-05-15 4/A A $0.00 $0 D/D 3,750 24,750 0 -
FPRX Five Prime Therapeutics I... EVP, Chief Scientific Officer   •       –      –    2018-05-10 4 A $0.00 $0 D/D 3,750 24,750 0 -
FPRX Five Prime Therapeutics I... SVP, Research   •       –      –    2017-09-01 4 A $0.00 $0 D/D 15,000 15,000 0 -

  7  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed